Insider Transactions Reported by 22 Insiders of RECURSION PHARMACEUTICALS, INC.

Symbol
RXRX on Nasdaq
Location
Salt Lake City, UT

Insiders trading volume in the past year

RECURSION PHARMACEUTICALS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lux Ventures IV, L.P. Former 10% Owner $138M 07 Dec 2021
Mubadala Investment Co PJSC 10%+ Owner $137M 02 Mar 2023
Zachary Bogue Director, 10%+ Owner $39.5M 03 Jul 2023
Blake Borgeson Director $30M -$961K -3.1% 02 Dec 2025
Dean Y. Li Director $15.6M 01 Oct 2025
MIC Capital Partners (Public) Parallel Cayman, LP 10%+ Owner $14.7M 01 Nov 2021
Michael Secora Chief Financial Officer $9.19M 15 Nov 2024
Christopher Gibson Chief Executive Officer, Director $4.11M -$8.31M -66.9% 19 Dec 2025
Ben R. Taylor Chief Financial Officer $3.39M 15 Dec 2025
Tina Marriott President and COO $3.13M 15 Nov 2024
Najat Khan Chief R&D Commercial Officer, Director $3.05M -$202K -6.23% 17 Nov 2025
Shafique Virani Chief Business Officer $1.45M 16 Jan 2024
David J. Mauro Chief Medical Officer $1.39M 15 Nov 2024
Ramona Doyle Chief Medical Officer $1.28M 16 May 2022
Zavain Dar Director $673K 01 Oct 2025
Franziska Michor Director $565K 18 Jun 2025
CHAVEZ R. MARTIN Director $530K 01 Apr 2024
Terry-Ann Burrell Director $514K 01 Jul 2024
ROBERT HERSHBERG Director $328K 18 Jun 2025
Namandje Bumpus Director $212K 18 Jun 2025
Elaine D. Sun Director $212K 18 Jun 2025
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC Other* 01 Nov 2021

Recent Insider Transactions by Companies or Individuals for RECURSION PHARMACEUTICALS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.